Patents by Inventor Martin A. Voet

Martin A. Voet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7255866
    Abstract: Methods for treating fibromyalgia by administering a therapeutically effective amount of a botulinum toxin to a patient with fibromyalgia.
    Type: Grant
    Filed: September 18, 2003
    Date of Patent: August 14, 2007
    Assignee: Allergan, Inc.
    Inventor: Martin A. Voet
  • Publication number: 20070092502
    Abstract: The present invention provides a method of treating glaucoma or preventing glaucoma in a person at risk of developing glaucoma, by applying to the eye of said person, an effective amount of an antibacterial agent having activity against the Heliocobacter Pylori bacteria to thereby eradicate, inhibit and/or control said bacteria.
    Type: Application
    Filed: June 26, 2006
    Publication date: April 26, 2007
    Inventor: Martin Voet
  • Publication number: 20070015838
    Abstract: The present invention provides a method of treating ocular hypertension or glaucoma which comprises administering to an animal having ocular hypertension or glaucoma therapeutically effective amount of a compound represented by the general formula I; wherein R is a lower alkyl radical, i.e. a C1-C6 alkyl radical, e.g. a methyl, ethyl or propyl radical. Most preferably said compound is (Z)-7-[1R, 2R, 2R, 5S)-3,5-Dihydroxy-2-[1E, 3S)-3-hydroxy-5-phenyl-1-pentyl]cyclopentyl]-5-N-ethylheptanamide.
    Type: Application
    Filed: July 10, 2006
    Publication date: January 18, 2007
    Inventor: Martin Voet
  • Publication number: 20060020037
    Abstract: This invention provides a method of treating autism comprising administering a therapeutically effective amount of a compound selected from the group consisting of tazarotenic acid, or ester or salt, thereof, to a person in need of such treatment. Preferably said compound is tazarotene.
    Type: Application
    Filed: July 22, 2004
    Publication date: January 26, 2006
    Inventor: Martin Voet
  • Publication number: 20050152924
    Abstract: A sinus headache can be treated by administration of a botulinum toxin to a patient. The botulinum toxin can be botulinum toxin type A and the botulinum toxin can be administered to or to the vicinity of a sinus membrane of a patient with a sinus headache.
    Type: Application
    Filed: November 19, 2004
    Publication date: July 14, 2005
    Applicant: ALLERGAN, INC.
    Inventor: Martin Voet
  • Patent number: 6838434
    Abstract: A sinus headache can be treated by administration of a botulinum toxin to a patient. The botulinum toxin can be botulinum toxin type A and the botulinum toxin can be administered to or to the vicinity of a sinus membrane of a patient with a sinus headache.
    Type: Grant
    Filed: May 2, 2003
    Date of Patent: January 4, 2005
    Assignee: Allergan, Inc.
    Inventor: Martin A. Voet
  • Publication number: 20040253274
    Abstract: Methods for reducing appetite by oral administration of a Clostridial toxin, such as a botulinum toxin.
    Type: Application
    Filed: June 11, 2003
    Publication date: December 16, 2004
    Applicant: Allergan, Inc.
    Inventor: Martin A. Voet
  • Patent number: 6821520
    Abstract: Methods for treating the hypothyroidism of Hashimoto's thyroiditis by local administration of a Clostridial toxin, such as a botulinum toxin, to the thyroid gland of a patient.
    Type: Grant
    Filed: March 15, 2002
    Date of Patent: November 23, 2004
    Assignee: Allergan, Inc.
    Inventors: Martin A. Voet, Stephen Donovan
  • Publication number: 20040219172
    Abstract: A sinus headache can be treated by administration of a botulinum toxin to a patient. The botulinum toxin can be botulinum toxin type A and the botulinum toxin can be administered to or to the vicinity of a sinus membrane of a patient with a sinus headache.
    Type: Application
    Filed: May 2, 2003
    Publication date: November 4, 2004
    Applicant: Allergan, Inc.
    Inventor: Martin A. Voet
  • Patent number: 6773711
    Abstract: Methods for treating the hypothyroidism of Hashimoto's thyroiditis by local administration of a neurotoxin, such as a botulinum toxin, to the thyroid gland of a patient.
    Type: Grant
    Filed: October 30, 2001
    Date of Patent: August 10, 2004
    Assignee: Allergan, Inc.
    Inventors: Martin A. Voet, Stephen Donovan
  • Patent number: 6723750
    Abstract: Method for treating dermal pre-melanoma conditions which include administering an effective amount of a photosensitive agent to a dermal pre-melanoma cell and activating the photosensitive agent, thereby treating a dermal pre-melanoma condition.
    Type: Grant
    Filed: March 15, 2002
    Date of Patent: April 20, 2004
    Assignee: Allergan, Inc.
    Inventor: Martin A. Voet
  • Publication number: 20040062776
    Abstract: Methods for treating fibromyalgia by administering a therapeutically effective amount of a botulinum toxin to a patient with fibromyalgia.
    Type: Application
    Filed: September 18, 2003
    Publication date: April 1, 2004
    Applicant: Allergan, Inc.
    Inventor: Martin A. Voet
  • Patent number: 6623742
    Abstract: Methods for treating fibromyalgia may include administering a therapeutically effective amount of a Clostridial toxin to a peripheral location on the body of a patient. This peripheral location is other than the site on the body where the pain emanates.
    Type: Grant
    Filed: September 17, 2001
    Date of Patent: September 23, 2003
    Assignee: Allergan, Inc.
    Inventor: Martin A. Voet
  • Publication number: 20030176411
    Abstract: Method for treating dermal pre-melanoma conditions which include administering an effective amount of a photosensitive agent to a dermal pre-melanoma cell and activating the photosensitive agent, thereby treating a dermal pre-melanoma condition.
    Type: Application
    Filed: March 15, 2002
    Publication date: September 18, 2003
    Applicant: Allergan Sales, Inc.
    Inventor: Martin A. Voet
  • Publication number: 20030054975
    Abstract: Methods for treating fibromyalgia may include administering a therapeutically effective amount of a Clostridial toxin to a peripheral location on the body of a patient. This peripheral location is other than the site on the body where the pain emanates.
    Type: Application
    Filed: September 17, 2001
    Publication date: March 20, 2003
    Applicant: Allergan Sales, Inc.
    Inventor: Martin A. Voet
  • Publication number: 20020102274
    Abstract: Methods for treating the hypothyroidism of Hashimoto's thyroiditis by local administration of a Clostridial toxin, such as a botulinum toxin, to the thyroid gland of a patient.
    Type: Application
    Filed: March 15, 2002
    Publication date: August 1, 2002
    Applicant: Allergan Sales, Inc.
    Inventors: Martin A. Voet, Stephen Donovan
  • Publication number: 20020081319
    Abstract: Methods for treating the hypothyroidism of Hashimoto's thyroiditis by local administration of a neurotoxin, such as a botulinum toxin, to the thyroid gland of a patient.
    Type: Application
    Filed: October 30, 2001
    Publication date: June 27, 2002
    Inventors: Martin A. Voet, Stephen Donovan
  • Patent number: 6358513
    Abstract: Methods for treating the hypothyroidism of Hashimoto's thyroiditis by local administration of a neurotoxin, such as a botulinum toxin, to the thyroid gland of a patient, thereby reducing an inhibitory effect upon thyroid hormone secretion.
    Type: Grant
    Filed: February 24, 2000
    Date of Patent: March 19, 2002
    Assignee: Allergan Sales, Inc.
    Inventors: Martin A. Voet, Stephen Donovan
  • Toy
    Patent number: D498271
    Type: Grant
    Filed: April 1, 2004
    Date of Patent: November 9, 2004
    Inventors: Martin A. Voet, Suzanne Mills-Winkler, Donna Tedea Tucker